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Toll-like receptors (TLRs) play an important role in the 
induction and regulation of the innate immune system or 
adaptive immune responses. Genetic variations within human 
TLRs have been reported to be associated with rheumatoid 
arthritis (RA). This study was conducted to investigate cor-
relation between SNP of downstream mononucleotide in 
signal transduction of Toll-like receptors and predisposing 
genes of RA. There  was obviously correlative between single 
nucleotide polymorphism and predisposing genes of RA. 
G-type of IL-1RAP rs766442 may be protecting genes of RA, 
while T-type alleles of IL-6R rs11265618 and IL-1RAP 
rs766442 may be susceptible genes of RA. In conclusion, 
the studies on the nucleis acid polymorphism in TLRs signal 
pathway contribute to disclose genes’ influence on the attack 
mechanism of RA, early diagnosis and treatment of RA.
Key words: Rheumatoid arthritis, Toll like receptors, gene, 
single nucleotide polymorphism.
Introduction. More and more studies have shown 
that natural immunity plays an important role in 
the attack and development of rheumatoid arthri-
tis (RA) [1]. Synovitis is the basic pathological 
changes of RA, and endogenous antigen is relieved 
and appears in RA synovial joint spontaneously 
with the stress, damage and necrosis of cells [2]. 
Activated antigen presentation cell (APC) can be 
activated by endogenous antigen, through recep-
tors on the surface. APC can capture and deal 
with antigens, and gather in synovial lining layer 
to release inflammatory agents. The inflammatory 
agents could damage cartilage and bone tissue, re-
sulting in the attack of RA [3].Toll-like receptors 
(TLRs) are a group of receptor molecules serving 
as the medium of natural immune response. There 
have been clues of TLRs’ significance already in 
the attack of RA [4, 5]. Both TLR2 and TLR4 are 
important participating molecules [6]. TLR2 can 
identify and react with many endogenous antigen 
epitopes, such as heat shock protein (HSP), hya-
luronic acid, fibronectin. While TLR4 can identify 
taxol, fusion protein, heat shock protein 70 (HSP70), 
fibronectin, heparin-sulfate proteoglycan fragments,
and human fibrinogen [7–9].
TLR signal transduction includes independent 
and dependent methods of myeloid differentia-
tion protein 88 (MYD88) [10]. Studies on Single 
Nucleotide Polymorphism (SNP) in links of TLR 
signal pathway contribute to learning about the 
hereditary background of RA attack, and accu-
mulate samples for the study on transformation of 
genes-properties.  
Tanaka et al. [11] found that high levels of 
IL-6 are shown to correlate with disease severity in 
RA, and contribute to RA onset and pathogenesis. 
Clinical trial has shown that the monoclonal Ab 
against the IL-6 receptor (IL-6R) is effective in the 
treatment of RA, which indicates that the IL-6R 
may play an important role in the RA pathogen-
esis [12]. IL-1 is the master mediator of inflam-
matory responses, and has been implicated in RA. 
The natural IL-1 receptor antagonist protein (IL-1 
RAP) could directly oppose the actions of IL-1 
[13]. Sacre et al. [14] discovered that the toll-like 
receptor adaptor protein MYD88 contributes to the 
inflammatory and destructive processes in a hu-
man model of RA. Zhu et al. [15] hypothesized 
that the TRAF6 is involved in the pathogenesis 
of inflammation and osteoclast differentiation, and 
correlated with the severity in RA. So, the present 
study intends to adopt the case-control approach, 
takes MYD88, TRAF6, IL-1RAP, IL-6, and IL-6R 
as candidate genes, chooses SNP sites, and inquires 
into the relations between these genes and RA.
Materials and methods. Ethics statements. Writ-
ten, informed consent was obtained from all pa-
tients prior to include into the study. In the case of 
minors, the consent was provided by the parents. 
This study was approved by the Ethics committee of 
the Medical Faculty of Shandong-University Jinan 
in China. The study protocol adhered to the ethical 
principles for medical research involving human 
subjects of the Helsinki Declaration.© X. LIU, J. XU, C.D. HU, Z.L. PAN, Y.C. ZHANG, 2014
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Study population. Our study population com-
prised 350 individuals of Han people in China, 
including 162 patients with RA, and 188 healthy 
unrelated individuals as control. The diagnosis of 
RA patients was based on established guidelines 
according to RA diagnostic criteria from America 
Association of Rheumatism˄ACR˅in 1987 [16]. 
All patients excluded autoimmune disease, such as 
Systemic Lupus Erythematosus (SLE), Dermato-
myositis or Polymyositis (DM/PM), diabetes, and 
thyroid diseases. The RA group would be com-
pared with control group whose members are from 
physical examination department in Shandong Pro-
vincial Hospital. The data for cases with RA and 
controls were shown in Table 1.  
SNP selection. First, data from the National Cen-
ter for Biotechnology Information were used to select 
a total of 9 SNPs. These SNPs could capture most 
of the genetic diversity across the TRAF6 and Myd88 
loci (5 SNPs for TRAF6, including: rs76834869, 
rs116937713, rs5030445, rs117428647, rs5030416; 
4 SNPs for MYD88 including: rs7744, rs117598704, 
rs118081234, rs117074408), with an r2 threshold set 
to 0.8 and minor allele frequency (MAF) of 10 %, 
according to the information of CHB of the Hap-
Map project. Secondly, the SNPs primer or probe 
design for which had failed were excluded (4 SNPs 
for TRAF6, including: rs76834869, rs116937713, 
rs117428647, rs5030416; 3 SNPs for MYD88 in-
cluding: rs117598704, rs118081234, rs117074408). 
Finally, 1 SNP for TRAF6 (rs5030445) were success 
genetyped by SYBR Green 1 real-time PCR [17, 18], 
and 1 SNP for MYD88 (rs7744) was gene-typed by 
TaqMan real-time PCR. 
One SNP primer sequence of IL-1RAP (rs766442), 
one SNP primer sequence of IL-6 (rs6946864) and 
2 SNP primer sequences of IL-6R (rs11265618, 
rs4845626) were obtained from Pro. Peter Gergre-
Table 1. Data for cases with rheumatoid 
arthritis and controls
Characteristic
Cases, 
n
Controls, 
n
Mean age of disease onset (years)
Proportion of females (%)
Total subjects available 
41.6
76.51
162
43.1
74.94
188
Table 2. Details of SNPs selected and genotyping sequence of primers/probes
Name
Chrosome 
position
SNP Primers/Probes
MYD88
TRAF6
IL-1RAP
IL-6 
IL-6R
3p22-p21.3
11p12 
3q28 
7p21
1q21.3
rs7744
rs5030445
rs766442
rs6946864
rs11265618
rs4845626
CAATGTACCAGTATTTATACCTCTA[A/G]TGAAGCACAGAGA-
GAGGAAGAGAGC
A GCGGGCGAGGAAGTGAGAAGGGACTGTAT
G GCGGGCAGGGCGGCGAGGAAGTGAGAAGGGACTGTAC
F AGTATTTTTAAAGAAAGTATTAACTGAAGGCTCTACC
G GCGGGCAGGGCGGCGGCATCAAGCTCTACATATATTAG
T GCGGGCGGCATCAAGCTCTACATATATTAT
R GGTGTAACATGAATACATAAAACTGC
G GCGGGCAGGGCGGCGGGAGACACATGTAAGTCATCATT
CTCGG
T GCGGGCGGGAGACACATGTAAGTCATCATTCTCGT
R GAGATGCTACTACTCTCTCTATGTCTACTAGAATTG
C GCGGGCAGGGCGGCGCACTATTGGCTGACTTTTCTGAAG
T GCGGGCGCACTATTGGCTGACTTTTCTGAAA 
F GGTCATTGGTTTTGTCATTCATTTCC
F GGATTAGAGCCATCCCTGTTCTCA
G GCGGGCAGGGCGGCTTGTCAGAGCCTGGACTGTATCC
T GCGGGCTTGTCAGAGCCTGGACTGTATCA
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son. The SNP sites of all these genes are shown in 
Table 2. 
DNA extraction. A RelaxGene blood DNA system 
was used for DNA extraction. From all participants, 
blood samples were taken, and genomic DNA was 
isolated by using DNA isolation kit purchased from 
TIANGEN BIOTECH (Beijin, China) according 
to the manufacturer’s guidelines.
Genotyping. Six SNPs (rs5030445, rs7744, rs766442,
rs6946864,rs11265618,rs4845626) were genotyped 
by the method of SYBR Green I real-time PCR. 
One SNP (rs7744) was genotyped by the method 
of TaqMan real-time PCR. All SNP analysis were 
performed using a LightCycler® 480 Instrument 
system (Roche Diagnostics, Mannheim, Germany) 
[17, 18]. The total volume of the TaqMan real-time 
PCR was 10 l containing 25 ng of genomic DNA, 
TaqMan Universal PCR Master Mix 5 l, 0.25 l 
of TaqMan probe (Applied Biosystems Inc.). The 
PCR comprised a pre-incubation step (95 ºC for 
10 min), 40 cycles (95 ºC for 15 sec, 60 ºC for 
1 min) and a cooling step (40 ºC for 30 sec). 
The total volume of the SYBR Green I real-
time PCR was 20 l containing 25 ng of genomic 
DNA, 10×PCR buffer, 2.5 mM of dNTP Mix, 
0.4 M of forward and reverse primer, 0.8 M of 
another primer, SYBR Green I and 5 U/l Taq 
HS (above-mentioned obtained from TaKaRa Bio-
technology (Dalian), China). The PCR comprised 
an initial denaturation step (95 ºC for 5 min), 31 
cycles (denaturation at 95 ºC for 10 sec, primer 
annealing at 60 ºC for 15 sec, extension at 72 ºC 
for 15 sec). The melting curve analysis comprised a 
heating step (95 ºC for 5 sec), a step rapidly lowering 
the temperature to 65 ºC and holding for 1 min. 
The final step was cooling the temperature down 
to 40 ºC for 30 sec.
Statistical analysis. Each genetic marker was 
tested for Hardy-Weinberg equilibrium in the con-
trol population [19, 20]. Single-marker allelic tests 
were performed with Fisher’s exact test. All tests 
were two-tailed, considering P values < 0.05 as 
significant. Both allelic and genotypic associations 
between single SNPs and RA susceptibility were 
analyzed using Ȥ2 tests [21].
Results. Hardy-Weinberg equilibrium test was 
satisfied in the observed genotype frequencies for 
all groups. The genotype and allele distribution for 
studied polymorphic variants is shown in Table 3 
and 4 for the following results.
Genotype frequency and allele-frequency of MYD88 
rs7744. The results indicated that there were no 
statistically significant differences in genotype and 
allele distribution between case and control group 
(P = 0.904, P = 0.685). 
Genotype frequency and allele-frequency of TRAF6 
rs5030445. The statistically significant differences we-
re not found in genotype and allele distribution be-
tween case and control group (P = 0.419, P = 0.221).
Genotype frequency and allele-frequency of IL-
1RAP rs766442. From the results, we found that 
GG-homozygote was the rarest type and not found-
ed in RA case groups. Through Fisher’s test, there 
were statistically significant differences in genotype 
and allele distribution between case and control 
group (P = 0.038, P = 0.018).
Genotype frequency and allele-frequency of IL-6 
rs6946864. GT-heterozygote was the most common 
Table 3. Distribution of genotype frequency
Gene
Pa-
tients 
(n = 
= 162)
Cont-
rols (n = 
= 188)
Ȥ2 p
value
MYD88 rs7744
AA
AG
GG
TRAF6 rs5030445
AA
AG
GG
IL-1RAP rs766442
GG
GT
TT
IL-6 rs6946864
GG
GT
TT
IL-6R rs11265618
CC
CT
TT
IL-6R rs4845626
GG
GT
TT
60
82
20
1
36
125
0
30
132
34
93
35
129
31
2
131
30
1
74
92
22
3
50
135
3
51
134
53
98
37
167
20
1
166
21
1
0.202
1.742
6.564
2.418
5.684
3.802
0.904
0.419
0.038
0.299
0.058
0.149
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form for these two receptors groups, but the dif-
ference among GG-genotypes, TT-genotypes, and 
GT-genotypes had no statistical significance, so did 
G/T allele-frequency (P = 0.299, P = 0.228).
Genotype frequency and allele-frequency of IL-6R 
rs11265628 and rs4845626. For rs11265628, there 
were no statistically significant differences in geno-
type and allele distribution between case and con-
trol group (P = 0.058), and the difference in C/T 
allele-frequency had statistical significance˄P =
= 0.017).
For rs4845626, there were no statistically signifi-
cant differences in genotype and allele distribution 
between case and control group (P = 0.149, P = 
= 0.065).
Discussion. Signal transmission of TLRs. TLR 
is defined as a process that the membrane trans-
port receptors identify different ligands through 
the comprehensive repeating structure of leucine 
in structural domain outsides its cells [22, 23]. TLR 
signal medium active the signal pathway of inflam-
mation and withering. TLR/IL-1R signal path-
way can be realized through two ways: MYD88-
dependence and Myd88-independence [24]. The 
former one can be described as follows: 1) the 
combination of TIR structural domain between C-
terminal of Myd88 and TLR, L-1R, and IL-18R; 
2) collect IL-1R associated kinase (IRAK) in the 
N-terminal death domain; 3) the combination of 
tumor necrosis factor receptor-associated factor 6 
(TARF6), ȕ-type TAK1 and TAB1 and TAB2, get 
into downstream of signal transmission; 4) I-KB 
kinase (IKK1-IKK2-IKK) active-KB (NF-kB), or 
Mitogen-activated protein kinase (MARK) induce 
conveying of inflammation cells, such as IL-1, IL-
6, IL-12, TNF-Į, interferon (IFN) and adhesion 
molecules. Both ways are through activator protein 
(AP-1) [25–28]. TRAF6 is a kind of terminal ki-
nase signal to modify NF-kB and Jun, so the loss 
of TARF6 may lead to defection of TLR signal, 
restraining the activation of NF-kB and reducing 
the inflammation cells nosogenesis [29–31].
Two IL-6 signal transmission ways: Both of tra-
ditional receptors’ combination and dissolvable re-
ceptors’ combination need the participation of IL-
6R and membrane transport protein gp130 [32, 33]. 
Traditional signal transmission is the combination 
of IL-6 and IL-6R in the surface, and this complex 
cross-link with gp130 into homo-signal. The same 
result can be realized by sIL-6R, a dissolvable form 
of IL-6R, and this is the dissolvable way. These two 
transmission ways can be achieved by the cascading 
of Janus kinase/signal transducer and activator of 
transcription and mitogen-activated protein kinase 
(MARK). IL-6/IL-6R/gp130 complex crosslink 
with JAK in cytoplasm, and promotes the convey-
ing of Acute Phase Reactants (APA), and finally 
leads to the over-breed of inflammation cells and 
the damage of natural autoantibody [34–36].
The relevance between SNP and RA susceptible 
gene. TLR downstream molecules, such as MYD88, 
TARF6, IL-1RAP, IL-6, IL-6R, were related to the 
attack of RA. We have chosen 6 SNP sites (rs7744, 
rs5030445, rs766442, rs6946864, rs11265618, and 
rs4845626), and found that IL-1RAP rs766442 and 
IL-6R rs1126518 allele-frequency makes sense sta-
tistically. So this proves that there is obvious rel-
evance between nucleic acid polymorphism of IL-
1RAP, IL-6R and RA susceptible genes. And it also 
proved that G-type alleles of IL-1RAP rs766442 
may be protecting genes of RA, while T-type alleles 
of IL-6R rs11265618 and IL-1RAP rs766442 may 
be susceptible genes of RA. Moreover, statistical 
analysis also showed that there was no relevance 
Gene
Pa-
tients 
(n = 
= 162)
Cont-
rols (n =
 = 188)
Ȥ2 pvalue
MYD88 rs7744
A
G
TRAF6 rs5030445
A
G
IL-1RAP rs766442
G
T
IL-6 rs6946864
G
T
IL-6R rs11265618
C
T
IL-6R rs4845626
G
T
202
122
38
286
30
294
161
163
289
35
292
32
240
136
56
320
57
319
204
172
354
22
353
23
0.165
1.500
5.567
1.453
5.704
3.398
0.685
0.221
0.018
0.228
0.017
0.065
Table 4. Distribution of allele-frequency
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between MYD88 rs7744, TRAF6, IL-6 rs6946864 
with RA. But owing to limited number of samples, 
the result could not be exclusive of the possibility 
of False Negative Rate (FNR), and the sites with 
statistical meaning can be caused by False Positive 
Rate (FPR). So, there is a necessity to expand the 
number of samples, in that case, we can know the 
relevance between SNP in the downstream of TLRs 
signal transduction pathway and RA Susceptible 
genes.
In conclusion, the studies on the nucleis acid 
polymorphism in TLRs signal pathway contribute 
to disclose genes’ influence on the attack mecha-
nism of RA, early diagnosis and treatment of RA.
The study was supported by Shandong Pro-
vince young scientist in incentive fund (Grant 
¹ 2006BS03018) and National Natural Science 
Foundation of China (Grant ¹ 30801025).
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ÀÑÑÎÖÈÀÖÈß SNP Â ÃÅÍÀÕ 
ÝËÅÌÅÍÒÎÂ ÑÈÃÍÀËÜÍÛÕ ÏÓÒÅÉ TLR 
Ñ ÏÐÅÄÐÀÑÏÎËÎÆÅÍÍÎÑÒÜÞ 
Ê ÐÅÂÌÀÒÎÈÄÍÎÌÓ ÀÐÒÐÈÒÓ
Òîëë-ïîäîáíûå ðåöåïòîðû (TLRs) èãðàþò âàæíóþ 
ðîëü â èíäóêöèè è ðåãóëÿöèè âðîæäåííîé èììóí-
íîé ñèñòåìû èëè àäàïòèâíûõ èììóííûõ îòâåòàõ. 
Ïîêàçàíî, ÷òî ÷òî ãåíåòè÷åñêàÿ èçìåí÷èâîñòü TLRs 
÷åëîâåêà ñâÿçàíà ñ ðåâìàòîèäíûì àðòðèòîì (ÐÀ). Öå-
ëüþ íàñòîÿùåé ðàáîòû áûëî èçó÷åíèå êîððåëÿöèé 
ìåæäó îäíîíóêëåîòèäíûì ïîëèìîðôèçìîì â ñèã-
íàëüíîé òðàíñäóêöèè TLRs è ãåíàìè ïðåäðàñïî-
ëîæåííîñòè ê ÐÀ. G-òèï IL-1RAP rs766442 ìîãóò 
áûòü ãåíàìè, ïðåäîõðàíÿþùèìè îò ÐÀ, â òî âðåìÿ 
êàê àëëåëè T-òèïà IL-6R rs11265618 è IL-1RAP 
rs766442 ìîãóò áûòü ãåíàìè ÷óâñòâèòåëüíîñòè ê ÐÀ.
Èçó÷åíèå ïîëèìîðôèçìà íóêëåèíîâûõ êèñëîò â ñèã-
íàëüíîì ïóòè TLRs ìîæåò âíåñòè âêëàä â âûÿâëåíèå 
ó÷àñòèÿ ãåíîâ â ìåõàíèçìàõ ïðèñòóïîâ ÐÀ, ðàííþþ 
äèàãíîñòèêó è ëå÷åíèå ÐÀ. 
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